Indivior Pharmaceuticals, Inc.

INDV • NASDAQ

Indivior Pharmaceuticals, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Joseph J. Ciaffoni, with a market cap of $3.9B.

Market Cap$3.9B

Employees1.2K

CEOJoseph J. Ciaffoni

CountryUnited States of America

Healthcare

Drug Manufacturers - Specialty & Generic

Next EarningsApr 30, 2026 · In 6 daysBefore Market Open · Q1 2026

Income Statement Balance Sheet Cash Flow Business Segments

Financials

View all metrics

Indivior Pharmaceuticals, Inc. FAQ

Common questions about Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on April 30, 2026 before market open. Analysts estimate revenue of $272.8M.

Indivior Pharmaceuticals, Inc. has approximately 1,164 employees.

Indivior Pharmaceuticals, Inc.

Financials

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Indivior Pharmaceuticals, Inc. FAQ

When is Indivior Pharmaceuticals, Inc. 's next earnings date?

How many employees does Indivior Pharmaceuticals, Inc. have?

Cookie Preferences